These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29266179)

  • 1. Lecocytes mutation load declines with age in carriers of the m.3243A>G mutation: A 10-year Prospective Cohort.
    Langdahl JH; Larsen M; Frost M; Andersen PH; Yderstraede KB; Vissing J; Dunø M; Thomassen M; Frederiksen AL
    Clin Genet; 2018 Apr; 93(4):925-928. PubMed ID: 29266179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.
    de Laat P; Koene S; van den Heuvel LP; Rodenburg RJ; Janssen MC; Smeitink JA
    J Inherit Metab Dis; 2012 Nov; 35(6):1059-69. PubMed ID: 22403016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
    Niedermayr K; Pölzl G; Scholl-Bürgi S; Fauth C; Schweigmann U; Haberlandt E; Albrecht U; Zlamy M; Sperl W; Mayr JA; Karall D
    Congenit Heart Dis; 2018 Sep; 13(5):671-677. PubMed ID: 30133155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroplasmy and phenotype spectrum of the mitochondrial tRNA
    Liu G; Shen X; Sun Y; Lv Q; Li Y; Du A
    J Neurol Sci; 2020 Jan; 408():116562. PubMed ID: 31722256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative correlation between organ heteroplasmy, particularly hepatic heteroplasmy, and age at death revealed by post-mortem studies of m.3243A > G cases.
    Yagi K; Okazaki S; Ohbatake A; Nakaya M; Liu J; Arite E; Miyamoto Y; Ito N; Nakano K; Yamaaki N; Honoki H; Fujisaka S; Chujo D; Tsunoda SI; Yanagimoto K; Nozue T; Yamada M; Ooe K; Araki T; Nakashima A; Azami Y; Sodemoto Y; Tadokoro K; Nagano M; Noguchi T; Nohara A; Origasa H; Niida Y; Tada H
    Mol Genet Metab; 2023 Nov; 140(3):107691. PubMed ID: 37660570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome.
    Fayssoil A; Laforêt P; Bougouin W; Jardel C; Lombès A; Bécane HM; Berber N; Stojkovic T; Béhin A; Eymard B; Duboc D; Wahbi K
    Eur J Neurol; 2017 Feb; 24(2):255-261. PubMed ID: 27869334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotypic spectrum of fifty Czech m.3243A>G carriers.
    Dvorakova V; Kolarova H; Magner M; Tesarova M; Hansikova H; Zeman J; Honzik T
    Mol Genet Metab; 2016 Aug; 118(4):288-95. PubMed ID: 27296531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis.
    Scholle LM; Zierz S; Mawrin C; Wickenhauser C; Urban DL
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?
    Mancuso M; Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Donati A; Minetti C; Moggio M; Mongini T; Servidei S; Tonin P; Toscano A; Uziel G; Bruno C; Ienco EC; Filosto M; Lamperti C; Catteruccia M; Moroni I; Musumeci O; Pegoraro E; Ronchi D; Santorelli FM; Sauchelli D; Scarpelli M; Sciacco M; Valentino ML; Vercelli L; Zeviani M; Siciliano G
    J Neurol; 2014 Mar; 261(3):504-10. PubMed ID: 24375076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation.
    Tschampa HJ; Urbach H; Greschus S; Kunz WS; Kornblum C
    J Neurol; 2013 Apr; 260(4):1071-80. PubMed ID: 23196335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome.
    de Laat P; Fleuren LH; Bekker MN; Smeitink JA; Janssen MC
    Mitochondrion; 2015 Nov; 25():98-103. PubMed ID: 26455484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation contributes to purifying selection against the MELAS-associated m.3243A>G pathogenic variant in blood.
    Walker MA; Li S; Livak KJ; Karaa A; Wu CJ; Mootha VK
    J Inherit Metab Dis; 2024 Jul; 47(4):757-765. PubMed ID: 38499449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level.
    de Wit HM; Westeneng HJ; van Engelen BG; Mudde AH
    Neth J Med; 2012 Dec; 70(10):460-2. PubMed ID: 23230016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection rates and phenotypic spectrum of m.3243A>G in the MT-TL1 gene: a molecular diagnostic laboratory perspective.
    Chin J; Marotta R; Chiotis M; Allan EH; Collins SJ
    Mitochondrion; 2014 Jul; 17():34-41. PubMed ID: 24846800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population.
    Tatlisumak T; Putaala J; Innilä M; Enzinger C; Metso TM; Curtze S; von Sarnowski B; Amaral-Silva A; Jungehulsing GJ; Tanislav C; Thijs V; Rolfs A; Norrving B; Fazekas F; Suomalainen A; Kolodny EH
    J Neurol; 2016 Feb; 263(2):257-262. PubMed ID: 26566914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype.
    Kaufmann P; Engelstad K; Wei Y; Kulikova R; Oskoui M; Sproule DM; Battista V; Koenigsberger DY; Pascual JM; Shanske S; Sano M; Mao X; Hirano M; Shungu DC; Dimauro S; De Vivo DC
    Neurology; 2011 Nov; 77(22):1965-71. PubMed ID: 22094475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation.
    de Laat P; Rodenburg RJ; Smeitink JAM; Janssen MCH
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00523. PubMed ID: 30516030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Phenotype and Segregation of Mitochondrial 3243A>G Mutation in 2 Pairs of Monozygotic Twins.
    Maeda K; Kawai H; Sanada M; Terashima T; Ogawa N; Idehara R; Makiishi T; Yasuda H; Sato S; Hoshi K; Yahikozawa H; Nishi K; Itoh Y; Ogasawara K; Tomita K; Indo HP; Majima HJ
    JAMA Neurol; 2016 Aug; 73(8):990-3. PubMed ID: 27323007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.
    Geng X; Zhang Y; Yan J; Chu C; Gao F; Jiang Z; Zhang X; Chen Y; Wei X; Feng Y; Lu H; Wang C; Zeng F; Jia W
    Diabet Med; 2019 Jun; 36(6):776-783. PubMed ID: 30536471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.